Reviewed by wyvernfriend on
Reading updates
- Started reading
- 23 April, 2015: Finished reading
- 23 April, 2015: Reviewed
Hired by a Yale professor to investigate the suspicious unavailability of a critical chemotherapy drug, Erin Pulaski discovers that its manufacturer is imposing a shortage to enable billions in windfall profits, a finding that is complicated by the brutal murder of a top employee.